Synergistic and multidimensional regulation of plasminogen activator inhibitor type 1 expression by transforming growth factor type β and epidermal growth factor

Journal of Biological Chemistry

Volumn 287, Issue 15, 2012, Pages 12520-12528

  Song, Xiaoling ^a,b   Thalacker, Frederic W ^a   Nilsen Hamilton, Marit ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b 206 Carnegie Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING; CELL MIGRATION; CELLULAR MECHANISMS; COMBINED EFFECT; EFFECTIVE CONCENTRATION; EPIDERMAL GROWTH FACTORS; GROWTH FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATORS; PROTEIN LEVEL; RAPID CHANGES; RECOGNITION SITE; TISSUE REMODELING; TRANSCRIPTIONAL ACTIVATIONS; TRANSFORMING GROWTH FACTORS; TYROSINE KINASE;

AMINO ACIDS; CHEMICAL ACTIVATION; PHOSPHORYLATION; TISSUE;

ENZYME INHIBITION;

EPIDERMAL GROWTH FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; PAI 1 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; RNA STABILITY; TYPE I PLASMINOGEN ACTIVATOR INHIBITOR GENE;

ANIMALS; CELL LINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LUCIFERASES, RENILLA; MAP KINASE SIGNALING SYSTEM; MINK; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS, GENETIC; RNA STABILITY; RNA, MESSENGER; SMAD PROTEINS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

MUSTELA;

EID: 84859490690     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.338079     Document Type: Article

References (48)

1. Häggroth, L., Mattsson, C., Felding, P., and Nilsson, I. M. (1986) Plasminogen activator inhibitors in plasma and platelets from patients with recurrent venous thrombosis and pregnant women. Thromb. Res. 42, 585-594 (Pubitemid 16079685)
2. Loskutoff, D. J., Sawdey, M., and Mimuro, J. (1989) Type 1 plasminogen activator inhibitor. Prog. Hemost. Thromb. 9, 87-115
3. Sprengers, E. D., and Kluft, C. (1987) Plasminogen activator inhibitors. Blood 69, 381-387 (Pubitemid 17022002)
4. Dellas, C., and Loskutoff, D. J. (2005) Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thromb. Haemost. 93, 631-640 (Pubitemid 40485397)
5. Xu, Z., Castellino, F. J., and Ploplis, V. A. (2010) Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture. Blood 115, 2038-2047
6. Ghosh, A. K., and Vaughan, D. E. (2012) PAI-1 in tissue fibrosis. J. Cell. Physiol. 227, 493-507
7. Landin, K., Tengborn, L., Chmielewska, J., von Schenck, H., and Smith, U. (1991) The acute effect of insulin on tissue plasminogen activator and plasminogen activator inhibitor in man. Thromb. Haemost. 65, 130-133
8. Thalacker, F. W., and Nilsen-Hamilton, M. (1992) Opposite and independent actions of cyclic AMP and transforming growth factor β in the regulation of type 1 plasminogen activator inhibitor expression. Biochem. J. 287, 855-862
9. Thalacker, F. W., and Nilsen-Hamilton, M. (1987) Specific induction of secreted proteins by transforming growth factor-β and 12-O- tetradecanoylphorbol- 13-acetate. Relationship with an inhibitor of plasminogen activator. J. Biol. Chem. 262, 2283-2290
10. Peiretti, F., Alessi, M. C., Henry, M., Anfosso, F., Juhan-Vague, I., and Nalbone, G. (1997) Intracellular calcium mobilization suppresses the TNF-alpha-stimulated synthesis of PAI-1 in human endothelial cells. Indications that calcium acts at a translational level. Arterioscler. Thromb. Vasc. Biol. 17, 1550-1560 (Pubitemid 27387777)
11. Watanabe, A., Kurabayashi, M., Arai, M., Sekiguchi, K., and Nagai, R. (2001) Combined effect of retinoic acid and basic FGF on PAI-1 gene expression in vascular smooth muscle cells. Cardiovasc. Res. 51, 151-159 (Pubitemid 32523064)
12. Schneider, D. J., and Sobel, B. E. (1991) Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I. Implications for vascular disease in hyperinsulinemic states. Proc. Natl. Acad. Sci. U.S.A. 88, 9959-9963 (Pubitemid 21915754)
13. Hopkins, W. E., Westerhausen, D. R., Fujii, S., Billadello, J. J., and Sobel, B. E. (1991) Mediators of induction of augmented expression of plasminogen activator inhibitor type-1 in Hep G2 cells by platelets. Thromb. Haemost. 66, 239-245
14. Rheinwald, J. G., Jorgensen, J. L., Hahn, W. C., Terpstra, A. J., O'Connell, T. M., and Plummer, K. K. (1987) Mesosecrin. A secreted glycoprotein produced in abundance by human mesothelial, endothelial, and kidney epithelial cells in culture. J. Cell Biol. 104, 263-275
15. Wrana, J. L., Attisano, L., Cárcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X. F., and Massagué, J. (1992) TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71, 1003-1014
16. Zhou, S., Zawel, L., Lengauer, C., Kinzler, K. W., and Vogelstein, B. (1998) Characterization of human FAST-1, a TGFβ and activin signal transducer. Mol. Cell 2, 121-127 (Pubitemid 128378973)
17. Zawel, L., Dai, J. L., Buckhaults, P., Zhou, S., Kinzler, K. W., Vogelstein, B., and Kern, S. E. (1998) Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1, 611-617 (Pubitemid 128374697)
18. Nakabeppu, Y., and Nathans, D. (1991) A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell 64, 751-759 (Pubitemid 121001162)
19. van Zonneveld, A. J., Curriden, S. A., and Loskutoff, D. J. (1988) Type 1 plasminogen activator inhibitor gene. Functional analysis and glucocorticoid regulation of its promoter. Proc. Natl. Acad. Sci. U.S.A. 85, 5525-5529
20. Dölken, L., Ruzsics, Z., Rädle, B., Friedel, C. C., Zimmer, R., Mages, J., Hoffmann, R., Dickinson, P., Forster, T., Ghazal, P., and Koszinowski, U. H. (2008) High-resolution gene expression profiling for simultaneous kinetic parameter analysis of RNA synthesis and decay. RNA 14, 1959-1972
21. Verrecchia, F., Vindevoghel, L., Lechleider, R. J., Uitto, J., Roberts, A. B., and Mauviel, A. (2001) Smad3/AP-1 interactions control transcriptional responses to TGF-β in a promoter-specific manner. Oncogene 20, 3332-3340 (Pubitemid 32588981)
22. Zhang, Y., Feng, X. H., and Derynck, R. (1998) Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature 394, 909-913 (Pubitemid 28410915)
23. Labbé, E., Silvestri, C., Hoodless, P. A., Wrana, J. L., and Attisano, L. (1998) Smad2 and Smad3 positively and negatively regulate TGFβ-dependent transcription through the forkhead DNA-binding protein FAST2. Mol. Cell 2, 109-120 (Pubitemid 128378972)
24. Roberts, A. B., Anzano, M. A., Wakefield, L. M., Roche, N. S., Stern, D. F., and Sporn, M. B. (1985) Type β transforming growth factor. A bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. U.S.A. 82, 119-123 (Pubitemid 15168226)
25. Okada, H., Danoff, T. M., Kalluri, R., and Neilson, E. G. (1997) Early role of Fsp1 in epithelial-mesenchymal transformation. Am. J. Physiol. 273, F563-F574
26. Stolz, D. B., and Michalopoulos, G. K. (1997) Synergistic enhancement of EGF, but not HGF, stimulated hepatocyte motility by TGF-β1 in vitro. J. Cell. Physiol. 170, 57-68 (Pubitemid 27046523)
27. Fakhouri, F., Placier, S., Ardaillou, R., Dussaule, J. C., and Chatziantoniou, C. (2001) Angiotensin II activates collagen type I gene in the renal cortex and aorta of transgenic mice through interaction with endothelin and TGF-β. J. Am. Soc. Nephrol. 12, 2701-2710 (Pubitemid 33115417)
28. Mbalaviele, G., Sheikh, S., Stains, J. P., Salazar, V. S., Cheng, S. L., Chen, D., and Civitelli, R. (2005) β-Catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. J. Cell. Biochem. 94, 403-418 (Pubitemid 41420317)
29. Yang, J., Dai, C., and Liu, Y. (2002) Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J. Am. Soc. Nephrol. 13, 2464-2477
30. Fernandez-Pol, J. A., Hamilton, P. D., and Klos, D. J. (1989) Transcriptional regulation of proto-oncogene expression by epidermal growth factor, transforming growth factor β1, and triiodothyronine in MDA-468 cells. J. Biol. Chem. 264, 4151-4156 (Pubitemid 19072309)
31. Ranganathan, G., and Getz, M. J. (1990) Cooperative stimulation of specific gene transcription by epidermal growth factor and transforming growth factor type β1. J. Biol. Chem. 265, 3001-3004
32. Freytag, J., Wilkins-Port, C. E., Higgins, C. E., Carlson, J. A., Noel, A., Foidart, J. M., Higgins, S. P., Samarakoon, R., and Higgins, P. J. (2009) PAI-1 regulates the invasive phenotype in human cutaneous squamous cell carcinoma. J. Oncol. 2009, 963209
33. Schluns, K. S., Cook, J. E., and Le, P. T. (1997) TGF-β differentially modulates epidermal growth factor-mediated increases in leukemia-inhibitory factor, IL-6, IL-1α, and IL-1β in human thymic epithelial cells. J. Immunol. 158, 2704-2712 (Pubitemid 127470528)
34. Saha, D., Datta, P. K., Sheng, H., Morrow, J. D., Wada, M., Moses, H. L., and Beauchamp, R. D. (1999) Synergistic induction of cyclooxygenase-2 by transforming growth factor-β1 and epidermal growth factor inhibits apoptosis in epithelial cells. Neoplasia 1, 508-517
35. Song, J. W., Song, K. S., Choi, J. R., Kim, S. Y., and Rhee, J. H. (2006) Plasma level of IL-6 and its relationship to procoagulant and fibrinolytic markers in acute ischemic stroke. Yonsei Med. J. 47, 201-206
36. Johannessen, L. E., Knardal, S. L., and Madshus, I. H. (1999) Epidermal growth factor increases the level of the cyclin-dependent kinase (CDK) inhibitor p21/CIP1 (CDK-interacting protein 1) in A431 cells by increasing the half-lives of the p21/CIP1 transcript and the p21/CIP1 protein. Biochem. J. 337, 599-606
37. Dufourny, B., van Teeffelen, H. A., Hamelers, I. H., Sussenbach, J. S., and Steenbergh, P. H. (2000) Stabilization of cyclin D1 mRNA via the phosphatidylinositol 3-kinase pathway in MCF-7 human breast cancer cells. J. Endocrinol. 166, 329-338 (Pubitemid 30650570)
38. Stoll, S. W., and Elder, J. T. (1999) Differential regulation of EGF-like growth factor genes in human keratinocytes. Biochem. Biophys. Res. Commun. 265, 214-221
39. Lee, P. T., Liao, P. C., Chang, W. C., and Tseng, J. T. (2007) Epidermal growth factor increases the interaction between nucleolin and heterogeneous nuclear ribonucleoprotein K/poly(C)-binding protein 1 complex to regulate the gastrin mRNA turnover. Mol. Biol. Cell 18, 5004-5013
40. Le, P. T., Lazorick, S., Whichard, L. P., Haynes, B. F., and Singer, K. H. (1991) Regulation of cytokine production in the human thymus. Epidermal growth factor and transforming growth factor α regulate mRNA levels of interleukin 1α (IL-1α), IL-1β, and IL-6 in human thymic epithelial cells at a post-transcriptional level. J. Exp. Med. 174, 1147-1157
41. Jinno, Y., Merlino, G. T., and Pastan, I. (1988) A novel effect of EGF on mRNA stability. Nucleic Acids Res. 16, 4957-4966
42. Shapiro, D. J., Blume, J. E., and Nielsen, D. A. (1987) Regulation of messenger RNA stability in eukaryotic cells. BioEssays 6, 221-226
43. Wilkins-Port, C. E., Higgins, C. E., Freytag, J., Higgins, S. P., Carlson, J. A., and Higgins, P. J. (2007) PAI-1 is a critical upstream regulator of the TGF-β1/EGF-induced invasive phenotype in mutant p53 human cutaneous squamous cell carcinoma. J. Biomed. Biotechnol. 2007, 85208
44. Stern, H. M., Lin-Jones, J., and Hauschka, S. D. (1997) Synergistic interactions between bFGF and a TGF-β family member may mediate myogenic signals from the neural tube. Development 124, 3511-3523
45. Emmanuel, C., Foo, E., Medbury, H. J., Matthews, J., Comis, A., and Zoellner, H. (2002) Synergistic induction of apoptosis in human endothelial cells by tumor necrosis factor-α and transforming growth factor-β. Cytokine 18, 237-241
46. Paugh, B. S., Paugh, S. W., Bryan, L., Kapitonov, D., Wilczynska, K. M., Gopalan, S. M., Rokita, H., Milstien, S., Spiegel, S., and Kordula, T. (2008) EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCδ, and sphingosine kinase 1 in glioblastoma cells. FASEB J. 22, 455-465 (Pubitemid 351225582)
47. de Caestecker, M. P., Parks, W. T., Frank, C. J., Castagnino, P., Bottaro, D. P., Roberts, A. B., and Lechleider, R. J. (1998) Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev. 12, 1587-1592 (Pubitemid 28299510)
48. Nilsen-Hamilton, M., Hamilton, R. T., Allen, W. R., and Potter-Perigo, S. (1982) Synergistic stimulation of S6 ribosomal protein phosphorylation and DNA synthesis by epidermal growth factor and insulin in quiescent 3T3 cells. Cell 31, 237-242 (Pubitemid 13215209)